Facilitates rapid cell invasion and neovascularization
DermiSphereTMhDRT is an advanced biphasic biomaterial that features a novel microarchitecture comprised of differential density interfaces created by combining a collagen based hydrogel with more dense collagen microspheres. DermiSphereTMhDRT facilitated cell invasion throughout the template 3 days after placement and becomes fully vascularized in just 7 days when vigorously tested pre-clinically.1
DUAL RESORPTION TECHNOLOGY
Fosters an optimal healing environment to support tissue regeneration
Designed with different rates of resorption, the less dense hydrogel component is rapidly replaced by the patient’s own collagen, while the denser microspheres are replaced more slowly enabling the deposition of stable vascularized neodermal tissue.
The DermiSphereTM Difference
In a pre-clinical study, DermiSphereTMhDRT facilitated fast and effective cellular invasion and vascularization of the template, leading to early, reliable deposition of functional neodermal tissue. By Day 3, DermiSphereTMhDRT demonstrated 100% wound bed incorporation and fully vascularized the template by Day 7 (Figure 1).1 Assessment of the newly formed dermal tissue revealed robust dermal thickness in DermiSphereTMhDRT treated wounds of 1.5mm on day 7.1
MAXIMIZED CONFORMABILITY
A pliable biomaterial that conforms to native tissue
The collagen hydrogel formula is designed to maximize conformability, ensuring that DermiSphereTM hDRT maintains intimate contact with the wound bed, even in irregular wound topographies, ensuring support of the wound healing process.
IMPROVED EASE OF USE
A translucent template that supports multidirectional cell invasion
DermiSphereTM hDRT is omnidirectional and can be applied or adjusted in any direction without compromising its fit or function. Additionally, it can be trimmed in the wound bed, improving its ease of use and simplifying the need to manage it clinically.